nodes	percent_of_prediction	percent_of_DWPC	metapath
Decamethonium—BCHE—diaphragm—ovarian cancer	0.12	0.248	CbGeAlD
Decamethonium—CHRNG—myometrium—ovarian cancer	0.0668	0.139	CbGeAlD
Decamethonium—CHRNE—testis—ovarian cancer	0.0629	0.131	CbGeAlD
Decamethonium—CHRNG—bone marrow—ovarian cancer	0.0368	0.0763	CbGeAlD
Decamethonium—CHRNB1—uterine cervix—ovarian cancer	0.0266	0.0551	CbGeAlD
Decamethonium—CHRNB1—female gonad—ovarian cancer	0.0181	0.0376	CbGeAlD
Decamethonium—CHRNB1—vagina—ovarian cancer	0.018	0.0374	CbGeAlD
Decamethonium—CHRNB1—testis—ovarian cancer	0.0161	0.0333	CbGeAlD
Decamethonium—BCHE—myometrium—ovarian cancer	0.0145	0.0302	CbGeAlD
Decamethonium—ACHE—testis—ovarian cancer	0.0139	0.0289	CbGeAlD
Decamethonium—CHRNB1—lymph node—ovarian cancer	0.0116	0.0242	CbGeAlD
Decamethonium—BCHE—uterine cervix—ovarian cancer	0.0113	0.0235	CbGeAlD
Decamethonium—BCHE—endometrium—ovarian cancer	0.0102	0.0212	CbGeAlD
Decamethonium—ACHE—lymph node—ovarian cancer	0.0101	0.0209	CbGeAlD
Decamethonium—BCHE—uterus—ovarian cancer	0.00944	0.0196	CbGeAlD
Decamethonium—BCHE—female reproductive system—ovarian cancer	0.00848	0.0176	CbGeAlD
Decamethonium—BCHE—bone marrow—ovarian cancer	0.00801	0.0166	CbGeAlD
Decamethonium—BCHE—vagina—ovarian cancer	0.00767	0.0159	CbGeAlD
Decamethonium—BCHE—testis—ovarian cancer	0.00685	0.0142	CbGeAlD
Decamethonium—BCHE—lymph node—ovarian cancer	0.00496	0.0103	CbGeAlD
Decamethonium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000801	0.00155	CbGpPWpGaD
Decamethonium—BCHE—Phospholipid metabolism—PIK3CB—ovarian cancer	0.000793	0.00153	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.00079	0.00152	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—TUBB3—ovarian cancer	0.000785	0.00152	CbGpPWpGaD
Decamethonium—ACHE—Phospholipid metabolism—PTEN—ovarian cancer	0.000768	0.00148	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000756	0.00146	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.00075	0.00145	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000746	0.00144	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—HDAC6—ovarian cancer	0.000745	0.00144	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—ATF3—ovarian cancer	0.000743	0.00143	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—ovarian cancer	0.000741	0.00143	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—APC—ovarian cancer	0.000741	0.00143	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000735	0.00142	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—MAPK1—ovarian cancer	0.000712	0.00137	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—CXCL8—ovarian cancer	0.000706	0.00136	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000695	0.00134	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000691	0.00133	CbGpPWpGaD
Decamethonium—BCHE—Phospholipid metabolism—PTEN—ovarian cancer	0.000685	0.00132	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—ATF3—ovarian cancer	0.000663	0.00128	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—YAP1—ovarian cancer	0.00066	0.00127	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CD—ovarian cancer	0.000652	0.00126	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—XIAP—ovarian cancer	0.000646	0.00125	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYTB—ovarian cancer	0.000644	0.00124	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000643	0.00124	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000634	0.00122	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.00063	0.00122	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—SMARCA4—ovarian cancer	0.00063	0.00122	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000629	0.00121	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HSD17B6—ovarian cancer	0.000621	0.0012	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000616	0.00119	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—EREG—ovarian cancer	0.000615	0.00119	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000614	0.00118	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000608	0.00117	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—MAPK1—ovarian cancer	0.000605	0.00117	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000602	0.00116	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000592	0.00114	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PGR—ovarian cancer	0.000576	0.00111	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—MAPK1—ovarian cancer	0.000575	0.00111	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYTB—ovarian cancer	0.000574	0.00111	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—HRAS—ovarian cancer	0.000571	0.0011	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CB—ovarian cancer	0.000568	0.0011	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PPP1CC—ovarian cancer	0.000563	0.00109	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—BRIP1—ovarian cancer	0.000563	0.00109	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000561	0.00108	CbGpPWpGaD
Decamethonium—ACHE—Phospholipid metabolism—PIK3CA—ovarian cancer	0.000542	0.00105	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000542	0.00105	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PARP1—ovarian cancer	0.000535	0.00103	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000535	0.00103	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—DLC1—ovarian cancer	0.000528	0.00102	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000526	0.00102	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—IL6ST—ovarian cancer	0.000512	0.000989	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000506	0.000977	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000504	0.000972	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PPP1CC—ovarian cancer	0.000502	0.000969	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—BRIP1—ovarian cancer	0.000502	0.000969	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000492	0.00095	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—PIK3CG—ovarian cancer	0.000492	0.00095	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—HRAS—ovarian cancer	0.000486	0.000938	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000485	0.000937	CbGpPWpGaD
Decamethonium—BCHE—Phospholipid metabolism—PIK3CA—ovarian cancer	0.000483	0.000933	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000482	0.00093	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000481	0.000929	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000476	0.00092	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000464	0.000896	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—HRAS—ovarian cancer	0.000462	0.000891	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000455	0.000878	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—NRAS—ovarian cancer	0.000438	0.000845	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PPP2R1A—ovarian cancer	0.000434	0.000838	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—PIK3CD—ovarian cancer	0.000433	0.000835	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—BCL9—ovarian cancer	0.00043	0.00083	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000427	0.000825	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—ovarian cancer	0.000419	0.00081	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000418	0.000807	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000415	0.000802	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000414	0.000799	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.00041	0.000792	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000404	0.00078	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—CXCL8—ovarian cancer	0.000399	0.00077	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—ovarian cancer	0.000399	0.00077	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—ovarian cancer	0.000399	0.00077	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—IL2—ovarian cancer	0.000381	0.000736	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—CXCL8—ovarian cancer	0.000379	0.000732	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—YAP1—ovarian cancer	0.000377	0.000729	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—PIK3CB—ovarian cancer	0.000377	0.000728	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—KRAS—ovarian cancer	0.000377	0.000728	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000374	0.000721	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000373	0.000719	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000366	0.000706	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CXCL8—ovarian cancer	0.000362	0.0007	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—MAPK1—ovarian cancer	0.000356	0.000686	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—IL2—ovarian cancer	0.000346	0.000669	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—ovarian cancer	0.000346	0.000668	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TERT—ovarian cancer	0.000345	0.000666	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.000341	0.000659	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—DOK1—ovarian cancer	0.00034	0.000656	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—YAP1—ovarian cancer	0.000337	0.00065	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000333	0.000643	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000332	0.000642	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000328	0.000634	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PPP1CC—ovarian cancer	0.00032	0.000617	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CAV1—ovarian cancer	0.000319	0.000616	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—MAPK1—ovarian cancer	0.000317	0.000612	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—FASN—ovarian cancer	0.000308	0.000594	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—ESR1—ovarian cancer	0.000308	0.000594	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—SLC5A5—ovarian cancer	0.000303	0.000584	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL6ST—ovarian cancer	0.000303	0.000584	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000301	0.000582	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000296	0.000571	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000293	0.000566	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—SLC2A1—ovarian cancer	0.000292	0.000564	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—APC—ovarian cancer	0.000291	0.000561	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CG—ovarian cancer	0.000291	0.000561	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—NRAS—ovarian cancer	0.000291	0.000561	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000286	0.000553	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—MMP2—ovarian cancer	0.000286	0.000552	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—HRAS—ovarian cancer	0.000285	0.000551	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYP1B1—ovarian cancer	0.00028	0.000541	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—MAPK3—ovarian cancer	0.000278	0.000537	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—FASN—ovarian cancer	0.000274	0.00053	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—SLC5A5—ovarian cancer	0.00027	0.000521	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—MAPK1—ovarian cancer	0.000265	0.000511	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—EGFR—ovarian cancer	0.000265	0.000511	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—SLC2A1—ovarian cancer	0.000261	0.000503	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CD—ovarian cancer	0.000256	0.000493	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000255	0.000493	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—MMP2—ovarian cancer	0.000255	0.000493	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—HRAS—ovarian cancer	0.000255	0.000492	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000253	0.000489	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—KRAS—ovarian cancer	0.00025	0.000483	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP1B1—ovarian cancer	0.00025	0.000483	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PPP2R1A—ovarian cancer	0.000249	0.00048	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000247	0.000477	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HDAC6—ovarian cancer	0.000242	0.000468	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000239	0.000461	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—CXCL8—ovarian cancer	0.000238	0.000459	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ABCB1—ovarian cancer	0.000231	0.000446	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—PIK3CA—ovarian cancer	0.00023	0.000444	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CXCL8—ovarian cancer	0.00023	0.000443	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—TYMS—ovarian cancer	0.000227	0.000438	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—ERBB2—ovarian cancer	0.000226	0.000436	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MTOR—ovarian cancer	0.000223	0.00043	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CB—ovarian cancer	0.000223	0.00043	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PPP2R1A—ovarian cancer	0.000222	0.000428	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000221	0.000426	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—CTNNB1—ovarian cancer	0.000219	0.000423	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—YAP1—ovarian cancer	0.000214	0.000414	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CXCL8—ovarian cancer	0.000214	0.000413	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—HRAS—ovarian cancer	0.000213	0.000411	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—CXCL8—ovarian cancer	0.000212	0.000409	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—XIAP—ovarian cancer	0.00021	0.000405	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CDKN1B—ovarian cancer	0.000209	0.000404	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—AKT1—ovarian cancer	0.000207	0.000399	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ABCB1—ovarian cancer	0.000206	0.000397	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CASP3—ovarian cancer	0.000205	0.000396	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SMARCA4—ovarian cancer	0.000205	0.000395	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL2—ovarian cancer	0.000205	0.000395	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—IL6—ovarian cancer	0.000204	0.000393	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—TYMS—ovarian cancer	0.000202	0.00039	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EREG—ovarian cancer	0.0002	0.000386	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CCND1—ovarian cancer	0.000199	0.000385	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CTNNB1—ovarian cancer	0.000197	0.000381	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—CTNNB1—ovarian cancer	0.000196	0.000378	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MMP9—ovarian cancer	0.000194	0.000374	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PTEN—ovarian cancer	0.000192	0.000372	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—AKT1—ovarian cancer	0.000188	0.000363	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PGR—ovarian cancer	0.000187	0.000361	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CAV1—ovarian cancer	0.000183	0.000353	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000176	0.00034	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000174	0.000337	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PARP1—ovarian cancer	0.000174	0.000336	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—VEGFA—ovarian cancer	0.000174	0.000336	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—STAT3—ovarian cancer	0.000172	0.000332	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—NRAS—ovarian cancer	0.000172	0.000332	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL6ST—ovarian cancer	0.000166	0.000321	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CG—ovarian cancer	0.000166	0.000321	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MAPK3—ovarian cancer	0.000164	0.000317	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CAV1—ovarian cancer	0.000163	0.000315	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CG—ovarian cancer	0.00016	0.000309	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MYC—ovarian cancer	0.00016	0.000309	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MAPK1—ovarian cancer	0.000156	0.000302	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—EGFR—ovarian cancer	0.000156	0.000302	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000156	0.0003	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000155	0.000299	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CG—ovarian cancer	0.000148	0.000286	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—KRAS—ovarian cancer	0.000148	0.000285	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CD—ovarian cancer	0.000146	0.000282	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PPP2R1A—ovarian cancer	0.000141	0.000273	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CD—ovarian cancer	0.000141	0.000271	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CA—ovarian cancer	0.000136	0.000262	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000135	0.000261	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TP53—ovarian cancer	0.000131	0.000254	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CD—ovarian cancer	0.00013	0.000252	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CXCL8—ovarian cancer	0.00013	0.00025	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CB—ovarian cancer	0.000127	0.000246	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—HRAS—ovarian cancer	0.000126	0.000243	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—IL2—ovarian cancer	0.000124	0.000239	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CB—ovarian cancer	0.000123	0.000237	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL6—ovarian cancer	0.00012	0.000232	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CXCL8—ovarian cancer	0.000118	0.000227	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CB—ovarian cancer	0.000114	0.00022	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL2—ovarian cancer	0.000113	0.000217	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TERT—ovarian cancer	0.000112	0.000217	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—AKT1—ovarian cancer	0.000111	0.000214	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PTEN—ovarian cancer	0.00011	0.000213	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CAV1—ovarian cancer	0.000104	0.0002	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ESR1—ovarian cancer	0.0001	0.000193	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL6ST—ovarian cancer	9.83e-05	0.00019	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PTEN—ovarian cancer	9.83e-05	0.00019	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—APC—ovarian cancer	9.45e-05	0.000182	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CG—ovarian cancer	9.45e-05	0.000182	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—NRAS—ovarian cancer	9.45e-05	0.000182	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—MAPK3—ovarian cancer	9.05e-05	0.000175	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—MAPK1—ovarian cancer	8.61e-05	0.000166	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—EGFR—ovarian cancer	8.61e-05	0.000166	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CD—ovarian cancer	8.31e-05	0.00016	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CA—ovarian cancer	8.23e-05	0.000159	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—KRAS—ovarian cancer	8.13e-05	0.000157	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CA—ovarian cancer	7.77e-05	0.00015	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CA—ovarian cancer	7.47e-05	0.000144	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ERBB2—ovarian cancer	7.34e-05	0.000142	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MTOR—ovarian cancer	7.24e-05	0.00014	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CB—ovarian cancer	7.24e-05	0.00014	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCL8—ovarian cancer	6.96e-05	0.000134	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CA—ovarian cancer	6.93e-05	0.000134	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—HRAS—ovarian cancer	6.91e-05	0.000133	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CDKN1B—ovarian cancer	6.8e-05	0.000131	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—AKT1—ovarian cancer	6.72e-05	0.00013	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CASP3—ovarian cancer	6.66e-05	0.000129	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL2—ovarian cancer	6.65e-05	0.000128	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL6—ovarian cancer	6.62e-05	0.000128	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCND1—ovarian cancer	6.48e-05	0.000125	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CTNNB1—ovarian cancer	6.42e-05	0.000124	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—AKT1—ovarian cancer	6.35e-05	0.000123	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MMP9—ovarian cancer	6.29e-05	0.000121	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PTEN—ovarian cancer	6.26e-05	0.000121	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—AKT1—ovarian cancer	6.1e-05	0.000118	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—AKT1—ovarian cancer	5.66e-05	0.000109	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	5.65e-05	0.000109	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—STAT3—ovarian cancer	5.6e-05	0.000108	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NRAS—ovarian cancer	5.58e-05	0.000108	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	5.35e-05	0.000103	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MYC—ovarian cancer	5.2e-05	0.0001	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	5.09e-05	9.82e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EGFR—ovarian cancer	5.09e-05	9.82e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—KRAS—ovarian cancer	4.8e-05	9.27e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	4.41e-05	8.52e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TP53—ovarian cancer	4.27e-05	8.24e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HRAS—ovarian cancer	4.08e-05	7.88e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL6—ovarian cancer	3.91e-05	7.55e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—AKT1—ovarian cancer	3.61e-05	6.96e-05	CbGpPWpGaD
